ArticleJournal of thrombosis and thrombolysis2020

When to consider targeted therapies in thrombotic microangiopathies in the modern era: walking the tightrope between cost, safety, and efficacy.

Catherine R Murphree et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.